These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 2449107)
21. [Blood volume replacement using hydroxyethyl starch or Dextran 60]. Hölscher B Infusionstherapie (1973); 1974 Apr; 1(4):281-5. PubMed ID: 4142945 [No Abstract] [Full Text] [Related]
22. Erythema multiforme following the infusion of hydroxyethyl starch. Klein RE; Mogollon G Transfusion; 1984; 24(2):166-7. PubMed ID: 6200969 [TBL] [Abstract][Full Text] [Related]
24. Hemodynamic and oxygen transport effects of pentastarch in burn resuscitation. Waxman K; Holness R; Tominaga G; Chela P; Grimes J Ann Surg; 1989 Mar; 209(3):341-5. PubMed ID: 2466449 [TBL] [Abstract][Full Text] [Related]
25. An experimental study on the effect of plasma expanders on blood coagulability. Narita T; Matsumoto I; Kumazawa T; Ikezono E Bull Tokyo Med Dent Univ; 1979 Mar; 26(1):25-32. PubMed ID: 85502 [TBL] [Abstract][Full Text] [Related]
28. Hydroxyethyl-starch use and PBM: a necessary update to the Italian national guidelines. Biancofiore G; Vaglio S; Liumbruno GM Blood Transfus; 2016 May; 14(2):195-6. PubMed ID: 27177414 [No Abstract] [Full Text] [Related]
29. [Long term tolerance of highly dosed infusions of hydroxylethylstarch and dextran 60 in normovolemic rabbits]. Hölscher B Infusionsther Klin Ernahr; 1975 Jun; 2(3):215-20. PubMed ID: 52620 [TBL] [Abstract][Full Text] [Related]
30. Intraoperative hydroxyethyl starch 70/0.5 administration may increase postoperative bleeding: a retrospective cohort study. Fukushima T; Uchino S; Fujii T; Takinami M; Uezono S J Anesth; 2017 Jun; 31(3):330-336. PubMed ID: 28341919 [TBL] [Abstract][Full Text] [Related]
31. [Low-molecular-weight hydroxyethyl starch or low-molecular-weight dextran in acute inner ear disorders? A randomized comparative study]. Pilgramm M; Vestner HJ; Schumann K Laryngol Rhinol Otol (Stuttg); 1986 Jul; 65(7):377-80. PubMed ID: 2427904 [TBL] [Abstract][Full Text] [Related]
32. [Hemodilution in acute ischemic insults. Comparative study on the clinical and hemorheologic effectiveness of 10% HES 200/0.5 and 10% dextran 40]. Schneider R; Hacke W; Kiesewetter H; Jung F Fortschr Med; 1985 Nov; 103(44):1031-4. PubMed ID: 2416658 [No Abstract] [Full Text] [Related]
33. New dosage regimens for HES during intensive leukapheresis. Mishler JM Transfusion; 1978; 18(1):126-7. PubMed ID: 75600 [No Abstract] [Full Text] [Related]
34. [Hydroxyethyl starch-(HES)-induced pruritus as secondary complication of an occupational accident]. Weisshaar E; Ständer S; Metze D; Diepgen TL Hautarzt; 2004 Jun; 55(6):558-61. PubMed ID: 15141295 [TBL] [Abstract][Full Text] [Related]
35. Time to assess alternatives to hydroxyethyl starch to use instead of 0.9% saline in fluid replacement. Cruickshanks M; Drummond GB; Paterson-Brown S; Powell AG BMJ; 2013 Jul; 347():f4651. PubMed ID: 23900815 [No Abstract] [Full Text] [Related]
36. Why hydroxyethyl starch solutions should NOT be banned from the operating room. De Hert S; De Baerdemaeker L Anaesthesiol Intensive Ther; 2014; 46(5):336-41. PubMed ID: 25432553 [TBL] [Abstract][Full Text] [Related]
37. [EMA-decision on HES-restrictions]. Svensén C; Hjelmqvist H Lakartidningen; 2014 Jan 8-14; 111(1-2):20. PubMed ID: 24498715 [No Abstract] [Full Text] [Related]